Report an error

Spotted something inaccurate in “GLP-1 Agonists May Cut 10-Year CVD Risk 20% in High-Risk Primary Prevention”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.